Browsing Journal Articles by Author "Chatterjee, Chirantan"
Now showing items 1-15 of 15
-
Balancing affordability and availability in a drug patent regime
Pingali, Viswanath; Chatterjee, Chirantan (Economic and Political Weekly, 2015)India needs to fi nd an optimal patenting regime that will safeguard incentives for innovation while simultaneously ensuring that medicines are available at reasonable prices. -
Competition law in india: perspectives
Pingali, Viswanath; Chaudhuri, Manas Kumar; Malik, Payal; Tamara, Ram; Kakkar, Avaantika; Chatterjee, Chirantan; Mondal, Shamim; Sokol, D Daniel (Sage, 2016)In 2002, the Parliament of India enacted the Competition Act, replacing the archaic Monopoly and Restrictive Trade Practices Act (popularly referred to as the MRTP Act) of 1969. The primary goal of the Act, as stated in ... -
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
Pingali, Viswanath; Chatterjee, Chirantan; Kubo, Kensuke (Elsevier, 2015)This paper empirically examines the consumer welfare implications of changes in government policies related to patent protection and compulsory licensing in the Indian market for oral anti-diabetic (OAD) medicines. In ... -
Crocin or paracetamol: what should the doctor prescribe?
Chatterjee, Chirantan; Kensuke, Kubo; Pingali, Viswanath (Economic & Political Weekly, 2013)As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes ... -
Cross-border environmental regulation and firm labor demand
Chakraborty, Pavel; Chakrabarti, Anindya S.; Chatterjee, Chirantan (Elsevier, 2022-11-07)In 1994, due to environmental concerns, Germany banned a chemical called ‘Azo-dyes’, a primary input for the leather and textiles firms in India (a key exporter). Exploiting this as a quasi-natural experiment, we examine ... -
Did India’s price control policy for coronary stents create unintended consequences?
Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar (Social Science & Medicine, 2020)In February 2017, India capped the retail price of coronary stents and restricted the channel margin to bring Percutaneous Transluminal Coronary Angioplasty (PTCA) procedure, which uses coronary stents, within reach of ... -
From courts to markets: new evidence on enforcement of pharmaceutical bans in India
Chatterjee, Chirantan; Mohapatra, D. P.; Estay, M. (Social Science & Medicine, 2019)Regulatory enforcement of product safety standards given health concerns, whether it is in romaine lettuce, smartphones or cars, is emerging to be a challenge for global public health. This is particularly true for developing ... -
Generic competition and the incentives for early-stage pharmaceutical innovation
Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. (Elsevier, 2022-12-01)What impact has rising generic competition had on the nature and direction of pharmaceutical innovation? We find broad-based, strong evidence that pharmaceutical companies have diverted their new drug development efforts ... -
How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic
Chatterjee, Chirantan; Adbi, Arzi; Mishra, Anant (PubsOnLine, 2022-03-23)Global shocks bring unanticipated changes in the business environment of foreign multinational enterprises (MNEs) and rival domestic firms. We examine whether there is a difference between how MNEs and domestic firms react ... -
How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry
Bhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico (INFORMS: Institute for Operations Research and the Management Sciences, 2021-02-09)We study coercive institutional pressures as an impetus for firms to reposition across intraindustry boundaries. Integrating the literatures on strategic repositioning and submarkets, we predict that firms respond to ... -
Intellectual property regimes and wage inequality
Bhattacharya, Sourav; Chakraborty, Pavel; Chatterjee, Chirantan (Elsevier, 2021-07-19)We use The Patents (Amendment) Act, 2002 in India as a quasi-natural experiment to identify the causal effect of higher incentives for innovation on a firm’s compensation structure. We find that stronger intellectual ... -
Research and market structure: evidence from an antibiotic-resistant pathogenic outbreak
Aggarwal, Mayank; Chakrabarti, Anindya S.; Chatterjee, Chirantan; Higgins, Matthew J. (Elsevier, 2023-01)We provide causal evidence that upstream research shocks impact unconnected downstream product markets. Focusing on the Indian pharmaceutical market, we use a natural experiment involving a publication that identified a ... -
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
Higgins, Matthew J.; Yan, Xin; Chatterjee, Chirantan (Research Policy, 2020-09-12)We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and ... -
When the big one came: a natural experiment on demand shock and market structure in India’s influenza vaccine markets
Chatterjee, Chirantan; Adbi, Arzi; Drev, Matej; Mishra, Anant (John Wiley, 2018-08)This paper examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines ... -
Women’s disempowerment and preferences for skin lightening products that reinforce Colorism: experimental evidence from India
Adbi, Arzi; Chatterjee, Chirantan; Clarissa, Cortland; Kinias, Zoe; Singh, Jasjit (SAGE Publications, 2021-02-25)Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten ...